|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Świątkowska B, Szubert Z, Sobala W and
Szeszenia-Dąbrowska N: Predictors of lung cancer among former
asbestos-exposed workers. Lung Cancer. 89:243–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Devesa SS, Bray F, Vizcaino AP and Parkin
DM: International lung cancer trends by histologic type:
male:female differences diminishing and adenocarcinoma rates
rising. Int J Cancer. 117:294–299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Howlader N, Noone AM, Krapcho M, Garshell
J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,
Mariotto A, Lewis DR, Chen HS, Feuer EJ and Cronin KA: SEER Cancer
Statistics Review, 1975–2012. National Cancer Institute; Bethesda,
MD: http://seer.cancer.gov/csr/1975_2012/based on
November 2014 SEER data submission, posted to the SEER web site.
April. 2015
|
|
5
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al CONCORD Working Group, : Global surveillance of cancer
survival 1995–2009: Analysis of individual data for 25,676,887
patients from 279 population-based registries in 67 countries
(CONCORD-2). Lancet. 385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta SK: Role of Crizotinib in previously
treated non-small-cell lung cancer. South Asian J Cancer.
3:138–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Angulo P, Kaushik G, Subramaniam D,
Dandawate P, Neville K, Chastain K and Anant S: Natural compounds
targeting major cell signaling pathways: A novel paradigm for
osteosarcoma therapy. J Hematol Oncol. 10:102017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chanvorachote P, Chamni S, Ninsontia C and
Phiboonchaiyanan PP: Potential anti-metastasis natural compounds
for lung lancer. Anticancer Res. 36:5707–5717. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shanmugam MK, Lee JH, Chai EZ, Kanchi MM,
Kar S, Arfuso F, Dharmarajan A, Kumar AP, Ramar PS, Looi CY, et al:
Cancer prevention and therapy through the modulation of
transcription factors by bioactive natural compounds. Semin Cancer
Biol 40–41. 1–47. 2016.
|
|
11
|
Pan MH, Lai CS, Wu JC and Ho CT: Molecular
mechanisms for chemoprevention of colorectal cancer by natural
dietary compounds. Mol Nutr Food Res. 55:32–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo XF, Yang ZR, Wang J, Lei XF, Lv XG and
Dong WG: Synergistic antitumor effect of puerarin combined with
5-fluorouracil on gastric carcinoma. Mol Med Rep. 11:2562–2568.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng YP, Yang ZR, Guo XF, Jun W and Dong
WG: Synergistic effect of puerarin and 5-fluorouracil on
hepatocellular carcinoma. Oncol Lett. 8:2436–2442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang SF, Wang XL, Yang XQ and Chen N:
Autophagy-associated targeting pathways of natural products during
cancer treatment. Asian Pac J Cancer Prev. 15:10557–10563. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yanagihara K, Ito A, Toge T and Numoto M:
Antiproliferative effects of isoflavones on human cancer cell lines
established from the gastrointestinal tract. Cancer Res.
53:5815–5821. 1993.PubMed/NCBI
|
|
16
|
Tian F, Xu LH, Zhao W, Tian LJ and Ji XL:
The optimal therapeutic timing and mechanism of puerarin treatment
of spinal cord ischemia-reperfusion injury in rats. J
Ethnopharmacol. 134:892–896. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wong KH, Li GQ, Li KM, Razmovski-Naumovski
V and Chan K: Kudzu root: Traditional uses and potential medicinal
benefits in diabetes and cardiovascular diseases. J Ethnopharmacol.
134:584–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan Y, Zong J, Zhou H, Bian ZY, Deng W,
Dai J, Gan HW, Yang Z, Li H and Tang QZ: Puerarin attenuates
pressure overload-induced cardiac hypertrophy. J Cardiol. 63:73–81.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yeung DK, Leung SW, Xu YC, Vanhoutte PM
and Man RY: Puerarin, an isoflavonoid derived from Radix puerariae,
potentiates endothelium-independent relaxation via the cyclic AMP
pathway in porcine coronary artery. Eur J Pharmacol. 552:105–111.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Z and Li W: Induction of apoptosis by
puerarin in colon cancer HT-29 cells. Cancer Lett. 238:53–60. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Ma Y, Zheng Y, Song J, Yang X, Bi
C, Zhang D and Zhang Q: In vitro and in vivo anticancer activity of
a novel puerarin nanosuspension against colon cancer, with high
efficacy and low toxicity. Int J Pharm. 441:728–735. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang WG, Liu XF, Meng KW and Hu SY:
Puerarin inhibits growth and induces apoptosis in SMMC-7721
hepatocellular carcinoma cells. Mol Med Rep. 10:2752–2758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin YJ, Hou YC, Lin CH, Hsu YA, Sheu JJ,
Lai CH, Chen BH, Lee Chao PD, Wan L and Tsai FJ: Puerariae radix
isoflavones and their metabolites inhibit growth and induce
apoptosis in breast cancer cells. Biochem Biophys Res Commun.
378:683–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Research Council of the National
Academies, . Guide for the Care and Use of Laboratory Animals:
2011. The National Academies Press; Washington, DC: 2011
|
|
25
|
Ma Y, Gai Y, Yan J, Li J and Zhang Y:
Puerarin attenuates anoxia/reoxygenation injury through enhancing
Bcl-2 associated athanogene 3 Expression, a modulator of apoptosis
and autophagy. Med Sci Monit. 22:977–983. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu B, Wu Z, Li Y, Ou C, Huang Z, Zhang J,
Liu P, Luo C and Chen M: Puerarin prevents cardiac hypertrophy
induced by pressure overload through activation of autophagy.
Biochem Biophys Res Commun. 464:908–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei SY, Chen Y and Xu XY: Progress on the
pharmacological research of puerarin: A review. Chin J Nat Med.
12:407–414. 2014.PubMed/NCBI
|
|
28
|
Han J, Yu CQ and Shen W: Inhibitory
effects of puerarin on invasion and metastasis of oophoroma cells
HO-8910. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:632–635. 2009.(In
Chinese). PubMed/NCBI
|
|
29
|
Zhu G, Wang X, Wu S and Li Q: Involvement
of activation of PI3K/Akt pathway in the protective effects of
puerarin against MPP+-induced human neuroblastoma
SH-SY5Y cell death. Neurochem Int. 60:400–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi YH, Kong KR, Kim YA, Jung KO, Kil JH,
Rhee SH and Park KY: Induction of Bax and activation of caspases
during beta-sitosterol-mediated apoptosis in human colon cancer
cells. Int J Oncol. 23:1657–1662. 2003.PubMed/NCBI
|
|
33
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
